We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LIPUM.ST

Price
16.45
Stock movement up
+1.20 (7.87%)
Company name
Lipum AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
348.94M
Ent value
354.46M
Price/Sales
6583.85
Price/Book
7.31
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
136.69%
3 year return
-4.35%
5 year return
-
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

LIPUM.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales6583.85
Price to Book7.31
EV to Sales6687.98

FINANCIALS

Per share

Per share data
Current share count21.21M
EPS (TTM)-1.83
FCF per share (TTM)-3.63

Income statement

Income statement data
Revenue (TTM)53.00K
Gross profit (TTM)14.00K
Operating income (TTM)-36.76M
Net income (TTM)-39.24M
EPS (TTM)-1.83
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)26.42%
Operating margin (TTM)-69356.60%
Profit margin (TTM)-74037.74%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash12.87M
Net receivables52.62M
Total current assets65.98M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment160.00K
Total assets66.14M
Accounts payable3.91M
Short/Current long term debt11.78M
Total current liabilities16.63M
Total liabilities18.39M
Shareholder's equity47.75M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-77.61M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-77.61M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-82.18%
Return on Assets-59.33%
Return on Invested Capital-65.92%
Cash Return on Invested Capital-130.38%

STOCK INFORMATION

Stock chart

Stock price data
Open15.30
Daily high16.50
Daily low14.95
Daily Volume13K
All-time high26.40
1y analyst estimate15.00
Beta0.15
EPS (TTM)-1.83
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
LIPUM.STS&P500
Current price drop from All-time high-37.69%-12.89%
Highest price drop-77.84%-56.47%
Date of highest drop26 Apr 20249 Mar 2009
Avg drop from high-46.09%-11.07%
Avg time to new high251 days12 days
Max time to new high937 days1805 days
COMPANY DETAILS
LIPUM.ST (Lipum AB) company logo
Marketcap
348.94M
Marketcap category
Small-cap
Description
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthritis in particular. The company was incorporated in 2010 and is based in Umeå, Sweden.
Employees
5
Website
https://www.lipum.se
Investor relations
-
SEC filings
LIPUM.ST SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved